Bibliography
- Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 2004;3(8):711-5
- Pharmaprojects Update Analysis, May 2007, Volume 7 issue 1
- Exploring oncology's goldmine. Scrip Magazine 2005:10-2
- IMS oncology web page. Available from: http://www.imshealth.com/web/channel/0,3147,64576068_63872702_76488685,00.html
- Epsicom Cancer Drug News 2007;277:12-4
- Sarker D, Pacey S, Workman P. Use of pharmacokinetic/pharmacodynamic biomarkers to support rational cancer drug development. Biomarkers Med 2007;1(3):1-9
- Kamb A, Wee S, Lengauer C. Why is cancer drug discovery so difficult? Nat Rev Drug Discov 6(2):115-20
- Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005;5(11):845-56
- Glas AM, Floore A, Delahaye LJMJ, et al. Converting a breast cancer microarray signature into a high-throughput diagnostic test. Biomed Central Genomics 2006;278(7):2164-7
- The Pharmaprojects database. Available from: http://www.pharmaprojects.com